During the past decade, Orlando Immunology Center CRS conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Orlando Immunology Center CRS" #1 collaborator was "Gilead Sciences" with 1 trials as a collaborator, "HIV Vaccine Trials Network" with 1 trials as a collaborator, "Kowa Pharmaceuticals America, Inc." with 1 trials as a collaborator, "Massachusetts General Hospital" with 1 trials as a collaborator and "NEAT ID Foundation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Orlando Immunology Center CRS" are "HIV Infections" (2 trials), "Cardiovascular Diseases" (1 trials), "Monkeypox" (1 trials) and "SARS-CoV-2 Infection" (1 trials). Many other conditions were trialed in "Orlando Immunology Center CRS" in a lesser frequency.

Most popular intervention types in "Orlando Immunology Center CRS" are "Biological" (2 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "DNA plasmid vaccine" (1 trials), "DNA vaccine placebo" (1 trials), "HIV-1 recombinant adenovirus vaccine placebo" (1 trials) and "Moderna COVID-19 Vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Orlando Immunology Center CRS" are 3 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Orlando Immunology Center CRS". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Orlando Immunology Center CRS, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Orlando Immunology Center CRS, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".